A federal appeals court on Wednesday ruled against a lawsuit filed by representatives of the pharmaceutical industry challenging the federal Medicare drug price negotiation program, finding that drugmakers are not entitled to sell their products to Medicare at a price they would prefer. The U.S. Court of Appeals for the Fifth Circuit affirmed a prior…
Federal court rejects PhRMA challenge to Medicare drug price negotiation
Originally reported by The Hill. Read the full story at the original source.
Related Articles
GOP governor says he asked attorney general to look into ‘aggressive’ DOJ election observers
Wyoming Gov. Mark Gordon (R) on Wednesday said election monitors deployed to the state by the Department of Justice (DOJ...
Lutnick floats new way to add Trump’s name to Kennedy Center
Commerce Secretary Howard Lutnick suggested on Thursday a new way for President Trump’s name to reappear on the John F. ...
In Trump’s Washington, Ballooning National Debt Stirs Little Action
The relative indifference to the news that the U.S. government now owes $40 trillion demonstrates how drastically the po...
Trump coy on ‘economic D-Day’ measures toward Russia, China
President Trump shrugged off questions Thursday about whether countries are taking the U.S.’s “economic D-Day” threats s...